Companies
Cabio Biotech
RU-friendlyChinese fermentation-based health ingredient producer — ARA (arachidonic acid), DHA, CoQ10, and astaxanthin via precision fermentation at commercial scale.
- Country
- China
- Revenue
- ~CNY 800M
- Employees
- ~500 emp
ISO 22000
Halal
Kosher
Coverage
| CN | EU | US | |
|---|---|---|---|
| platform-chemicals | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Cathay Capital invested in 2020, acquiring a 25% stake | cathaycapital.com |
| Capacity | Relying on three major production bases | cabio.com |
| Certification | ISO 9001, FSSC 22000, Business Integrity Management Systems, USDA Organic (for DHA) | cabio.com |
| Regulatory approval | FDA GRAS (for ARA and DHA), EU Novel Food (for ARA and DHA) | cabio.com |
| Production site | Three major production bases, including Jiangxia and Gedian factories in Wuhan | cabio.com |
| Headcount | 595 employees as of December 31, 2025 | au.marketscreener.com · sg.finance.yahoo.com · stockanalysis.com · google.com · gurufocus.com |
| Revenue | 418.18 million CNY (TTM) | sg.finance.yahoo.com · gurufocus.com · reuters.com |
Independent sources: au.marketscreener.com · cathaycapital.com · google.com · gurufocus.com · reuters.com · sg.finance.yahoo.com · stockanalysis.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Arachidonic acid (ARA) microbial synthesis | platform-chemicals | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.